Sucralfate 1Gm + Oxetacaine 20Mg (Suspension)

Price 2 INR/ Bottle

Get a Price/Quote

MOQ : 100 Bottles

Sucralfate 1Gm + Oxetacaine 20Mg (Suspension) Specification

Origin of Medicine
Manufactured in India in accordance with pharmaceutical quality standards.

Indication
Used for the treatment of peptic ulcers, gastritis, and gastroesophageal reflux disease (GERD), providing both protective and pain-relieving effects.

Pacakaging (Quantity Per Box)
100 Ml

Dosage Form
Suspension form, designed for ease of administration and improved patient compliance.

Salt Composition
Sucralfate 1Gm + Oxetacaine 20Mg

Drug Type
General Medicines

Ingredients
Sucralfate 1Gm + Oxetacaine 20Mg (Suspension)

Physical Form
Liquid

Function
Other

Recommended For
As directed by physician

Dosage
As directed by physician

Dosage Guidelines
As directed by physician

Suitable For
Suitable For All

Quantity
100 Pieces

Storage Instructions
Store in a cool and dry place

Remote Battery Type
AAA

Refresh Rate
60 Hz

Operating System
Android

Smart TV Features
Built-in WiFi, Screen Mirroring

Viewing Angle
178

Sleep Timer
Yes

USB Ports
2

Sucralfate 1Gm + Oxetacaine 20Mg (Suspension) Trade Information

Minimum Order Quantity
100 Bottles

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
100 Ml

Main Export Market(s)
Asia

Main Domestic Market
All India

About Sucralfate 1Gm + Oxetacaine 20Mg (Suspension)

Get fast and effective relief with Sucralfate 1Gm + Oxetacaine 20Mg (Suspension), a popular choice for managing symptoms of peptic ulcers, gastritis, and GERD. Spotlighted as the best solution for providing both protective and pain-relieving effects, this suspension is perfect for easy and accurate dosage. Decorated with a reputation for improved patient compliance, its liquid form ensures smooth administration. Manufactured in India under strict pharmaceutical standards, each pack contains 100 ml, with 100 pieces per box, making it ideal for clinics and hospitals. Store in a cool, dry place for best results.

Commercial Use and Key Advantages

Sucralfate 1Gm + Oxetacaine 20Mg (Suspension) is widely used in hospitals, clinics, and pharmacies for the effective management of gastrointestinal conditions. Applied orally, it targets the gastrointestinal tract, offering rapid symptom relief and mucosal protection. A main advantage is its dual-action formula that soothes pain while providing a protective barrier, making it highly beneficial for patients with peptic ulcers and acid reflux disorders.

Sample Policy and Market Opportunities

We offer sample dispatching upon request, enabling clients to assess product quality and suitability before large-scale purchase. Our suspension enjoys strong market value, meeting the demands of both export and domestic markets. The main domestic market is India, with export opportunities extending globally. Clients can expect prompt delivery, competitive offers, and support for bulk orders, ensuring the perfect solution for healthcare providers and distributors alike.

FAQ's of Sucralfate 1Gm + Oxetacaine 20Mg (Suspension):

Q: How should Sucralfate 1Gm + Oxetacaine 20Mg (Suspension) be used?

A: Use the suspension strictly as directed by your physician. The recommended dosage and frequency depend on the individual patient's condition and requirements.

Q: What are the primary benefits of using this suspension?

A: This suspension offers a dual-action effect-providing a protective coating for ulcers and soothing pain, which is ideal for those suffering from peptic ulcers, gastritis, and GERD.

Q: When is this medicine typically prescribed?

A: It is commonly prescribed during episodes of gastrointestinal discomfort associated with peptic ulcers, gastritis, or acid reflux, as assessed by a healthcare professional.

Q: Where is this product manufactured and distributed?

A: Sucralfate 1Gm + Oxetacaine 20Mg (Suspension) is manufactured in India, conforming to high pharmaceutical quality standards and available for both domestic and international markets.